Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 206.49 Million EUR | 7.16% |
| 2022 | 192.69 Million EUR | -0.29% |
| 2021 | 193.26 Million EUR | -5.28% |
| 2020 | 204.03 Million EUR | 12.55% |
| 2019 | 181.27 Million EUR | 35.96% |
| 2018 | 133.33 Million EUR | 18.72% |
| 2017 | 112.3 Million EUR | -0.92% |
| 2016 | 113.34 Million EUR | -7.59% |
| 2015 | 122.65 Million EUR | -4.37% |
| 2014 | 128.25 Million EUR | -16.79% |
| 2013 | 154.12 Million EUR | 1.95% |
| 2012 | 151.18 Million EUR | 7.43% |
| 2011 | 140.72 Million EUR | 0.03% |
| 2010 | 140.68 Million EUR | 0.73% |
| 2009 | 139.66 Million EUR | -3.09% |
| 2008 | 144.11 Million EUR | 3.17% |
| 2007 | 139.69 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 204.53 Million EUR | 0.0% |
| 2023 Q2 | 204.28 Million EUR | 0.0% |
| 2023 Q3 | 206.49 Million EUR | 1.08% |
| 2023 FY | 206.49 Million EUR | 7.16% |
| 2023 Q4 | 206.49 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q4 | 190.95 Million EUR | 0.0% |
| 2022 Q3 | 190.95 Million EUR | -1.47% |
| 2022 Q2 | 193.79 Million EUR | 0.0% |
| 2022 FY | 192.69 Million EUR | -0.29% |
| 2021 Q4 | 186.75 Million EUR | 0.0% |
| 2021 Q3 | 186.75 Million EUR | -9.38% |
| 2021 FY | 193.26 Million EUR | -5.28% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | 206.08 Million EUR | 0.0% |
| 2020 Q3 | 197.32 Million EUR | 1.42% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 194.57 Million EUR | 0.0% |
| 2020 FY | 204.03 Million EUR | 12.55% |
| 2020 Q4 | 197.32 Million EUR | 0.0% |
| 2019 Q3 | 176.74 Million EUR | -0.45% |
| 2019 FY | 181.27 Million EUR | 35.96% |
| 2019 Q2 | 177.54 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q4 | 176.74 Million EUR | 0.0% |
| 2018 Q4 | 130.45 Million EUR | 0.0% |
| 2018 Q3 | 130.45 Million EUR | 18.26% |
| 2018 Q2 | 110.31 Million EUR | 0.0% |
| 2018 FY | 133.33 Million EUR | 18.72% |
| 2018 Q1 | - EUR | -100.0% |
| 2017 Q3 | 109.33 Million EUR | -0.45% |
| 2017 Q4 | 109.33 Million EUR | 0.0% |
| 2017 Q2 | 109.82 Million EUR | 0.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 FY | 112.3 Million EUR | -0.92% |
| 2016 Q4 | 110.15 Million EUR | 0.0% |
| 2016 FY | 113.34 Million EUR | -7.59% |
| 2016 Q3 | 110.15 Million EUR | -9.2% |
| 2016 Q2 | 121.31 Million EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2015 Q2 | 129.39 Million EUR | 3.23% |
| 2015 Q3 | 127.39 Million EUR | -1.54% |
| 2015 Q4 | 122.65 Million EUR | -3.72% |
| 2015 FY | 122.65 Million EUR | -4.37% |
| 2015 Q1 | 125.33 Million EUR | -2.27% |
| 2014 Q4 | 128.25 Million EUR | -16.47% |
| 2014 Q1 | - EUR | -100.0% |
| 2014 FY | 128.25 Million EUR | -16.79% |
| 2014 Q2 | 153.38 Million EUR | 0.0% |
| 2014 Q3 | 153.55 Million EUR | 0.11% |
| 2013 Q3 | 147.27 Million EUR | -0.16% |
| 2013 FY | 154.12 Million EUR | 1.95% |
| 2013 Q2 | 147.51 Million EUR | -1.07% |
| 2013 Q1 | 149.1 Million EUR | -1.38% |
| 2013 Q4 | 154.12 Million EUR | 4.65% |
| 2012 Q2 | 141.12 Million EUR | -0.56% |
| 2012 Q1 | 141.92 Million EUR | 0.85% |
| 2012 FY | 151.18 Million EUR | 7.43% |
| 2012 Q4 | 151.18 Million EUR | 8.49% |
| 2012 Q3 | 139.35 Million EUR | -1.25% |
| 2011 FY | 140.72 Million EUR | 0.03% |
| 2011 Q3 | 140.14 Million EUR | 1.27% |
| 2011 Q2 | 138.38 Million EUR | -0.47% |
| 2011 Q4 | 140.72 Million EUR | 0.41% |
| 2011 Q1 | 139.03 Million EUR | -1.17% |
| 2010 Q4 | 140.68 Million EUR | 0.0% |
| 2010 FY | 140.68 Million EUR | 0.73% |
| 2009 FY | 139.66 Million EUR | -3.09% |
| 2008 FY | 144.11 Million EUR | 3.17% |
| 2007 FY | 139.69 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 19.1 Billion EUR | 98.919% |
| Fresenius SE & Co. KGaA | 25.63 Billion EUR | 99.194% |
| LIMES Schlosskliniken AG | 16.6 Million EUR | -1143.524% |
| M1 Kliniken AG | 69.72 Million EUR | -196.136% |
| MEDICLIN Aktiengesellschaft | 742.57 Million EUR | 72.192% |
| RHÖN-KLINIKUM Aktiengesellschaft | 499.09 Million EUR | 58.627% |
| VITA 34 AG | 135.58 Million EUR | -52.303% |